Endogenous serum glucocorticoid concentrations, steroidogenic enzyme activity, and 90-day mortality in patients hospitalized with COVID-19: an observational cohort study.

Publication date: Aug 01, 2024

In the context of severe coronavirus disease 2019 (COVID-19) illness, we examined endogenous glucocorticoid concentrations, steroidogenic enzyme activity, and their correlation with inflammation and patient outcomes. This observational study included 125 hospitalized COVID-19 patients and 101 healthy individuals as a reference group. We utilized LC-MS to assess serum concentrations of 11-deoxycortisol, cortisol, and cortisone, as well as activities of steroidogenic enzymes (11β-hydroxylase and 11β-hydroxysteroid-dehydrogenase type 1). Cox proportional hazards regression analysis and competing risk analysis were employed to analyze associations between glucocorticoid concentrations and outcomes, adjusting for relevant factors. In patients with COVID-19, cortisol concentrations were higher and cortisone concentrations were lower compared to the reference group, while 11-deoxycortisol concentrations were similar. Steroidogenic enzyme activity favored cortisol production. Correlations between glucocorticoid concentrations and inflammatory markers were low. A doubling in concentrations cortisol, was associated with increased 90-day mortality and mechanical ventilation (HR: 2. 40 95% CI: (1. 03-5. 59) , P = 0. 042 and HR: 3. 83 (1. 19-12. 31), P = 0. 024). A doubling in concentrations of 11-deoxycortisol was also associated to mortality (HR: 1. 32 (1. 05-1. 67), P = 0. 018), whereas concentrations of cortisone were associated with mechanical ventilation (HR: 5. 09 (1. 49-17. 40), P = 0. 009). In conclusion, serum concentrations of glucocorticoid metabolites were altered in patients hospitalized with severe COVID-19, and steroidogenic enzyme activity resulting in the conversion of cortisone to biologically active cortisol was preserved, thus not favoring critical-illness-related corticosteroid insufficiency at the enzymatic level. Glucocorticoid release did not counterbalance the hyperinflammatory state in patients with severe COVID-19. High serum concentrations of 11-deoxycortisol and cortisol were associated with 90-day mortality, and high serum concentrations of cortisol and cortisone were associated with mechanical ventilation.

Concepts Keywords
Coronavirus COVID-19
Covid enzymes
Hydroxylase glucocorticoids
Severe inflammation
Steroidogenic mortality

Semantics

Type Source Name
disease MESH COVID-19
disease MESH inflammation
drug DRUGBANK Hydrocortisone
drug DRUGBANK Cortisone
disease IDO production
pathway REACTOME Release

Original Article

(Visited 2 times, 1 visits today)